Diagnostic advances have resulted in earlier and more frequent recogni
tion of pituitary tumors. Pituitary tumors cause problems owing to the
hormones they secrete or the effects of an expanding sellar mass-hypo
pituitarism, visual field abnormalities, and neurologic deficits. Prol
actin-secreting tumors (prolactinomas), which cause amenorrhea, galact
orrhea, and hypogonadism, constitute the most common type of primary p
ituitary tumors, followed by growth hormone-secreting tumors, which ca
use acromegaly, and corticotropin-secreting tumors, which cause Cushin
g's syndrome. Hypersecretion of thyroid-stimulating hormone, the gonad
otropins, or alpha-subunits is unusual. Nonfunctional tumors currently
represent only 10% of all clinically diagnosed pituitary adenomas, an
d some of these are alpha-subunit-secreting adenomas. Insights into th
e pathogenesis and biologic behavior of these usually benign tumors ha
ve been gained from genetic studies. We review some of the recent adva
nces and salient features of the diagnosis and management of pituitary
tumors, including biochemical and radiologic diagnosis, transsphenoid
al surgery, radiation therapy, and medical therapy. Each type of lesio
n requires a comprehensive but individualized treatment approach, and
regardless of the mode of therapy, careful follow-up is essential.